Tenax Therapeutics Prepares for High-Stakes Phase 3 Heart Failure Study Results

Biotech firm Tenax Therapeutics is set to release pivotal Phase 3 clinical trial results for an oral heart failure treatment, carrying massive implications for its stock value.

Loading lens…